**Specifications table**TableSubject area*Immunology*More specific subject area*Allergy*Type of data*Transcriptome, figures, tables*How data was acquired*High-throughput RNA sequencing using Illumina HiSeq. 1500, quantitative real-time PCR (qRT-PCR) using SYBR Green dye in a StepOnePlus™ Real-Time PCR system*Data format*Processed*Experimental factors*Wild-type versus mutant cells*Experimental features*Comparison of mRNA from PEP+/+ and PEP−/− mouse bone marrow derived mast cells (BMMCs) following activation with the antigen dinitrophenol and additional treatment with the glucocorticoid Dexamethasone.*Data source location*Karlsruhe Institute of Technology, Institute of Toxicology and Genetics Hermann-von-Helmholtz-Platz-1, 76344 Eggenstein-Leopoldshafen, Germany*Data accessibility<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108972>

**Value of the data**•This dataset is a transcriptomic analysis of bone marrow derived mast cells (BMMCs) from PEP+/+ and PEP−/− mice activated by antigen and additionally treated with glucocorticoids.•These data provide RNA-seq and qRT-PCR gene expression results to show the role of PEP in antigen-mediated mast cell activation and the inhibition of mast cell activation by glucocorticoids.•These data will serve as a reference point for antigen-mediated activation of mast cells and the antiallergic action of glucocorticoids.

1. Data {#s0005}
=======

The data show gene expression profiles of 16 RNA-sequencing (RNA-seq) samples, representing two replicates each from BMMCs isolated from wild-type (PEP+/+ ) and mutant (PEP−/−) mice:•sensitized with Immunoglobulin E (IgE) (500 ng/ml) for 3 h•sensitized with IgE (500 ng/ml) for 3 h and activated with the antigen dinitrophenol (DNP) (as dinitrophenyl -bovine serum albumin, 200 ng/ml) for 1 h•treated with dexamethasone (DEX) (10^−7^ M) for 8 h and IgE (500 ng/ml) for 3 h•treated with DEX (10^−7^ M) for 8 h, IgE (500 ng/ml) for 3 h and DNP (200 ng/ml) for 1 h.

The data are deposited under the Gene Expression Omnibus (GEO) number GEO: GSE [108972](108972){#ir0010} at <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108972>.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Preparation of the biological material {#s0015}
-------------------------------------------

BMMCs from PEP+/+ and PEP−/− mice were isolated by culturing bone marrow cells from the femur and tibia of male C57BL/6 mice aged 8--10 weeks in mast cell medium (IMDM supplemented with 10% foetal calf serum, 2 mM L-glutamine, 1 mM pyruvate, 100 ng stem cell factor/kit ligand, 5 ng/ml IL3, 50 µM β-mercaptoethanol, 1% penicillin/streptomycin 10,000 U/ml) in T-75 flask at 37 °C, 5% CO~2~ and 95% humidity in an incubator. The culture medium was changed every three days by centrifuging the suspended cells at 1300 rpm for 7 min and re-suspending the resulting pellet in fresh medium as previously described [@bib1]. The BMMCs were used after 4 weeks in culture as described in [Table 1](#t0005){ref-type="table"}.Table 1Outline of the different treatments administered prior to the transcriptomics study.Table 1**Sample nameGenotypeTreatment**PEP+/+ IgEPEST-domain-enriched tyrosine phosphatase WTImmunoglobulin EPEP+/+ IgE DNPPEST-domain-enriched tyrosine phosphatase WTImmunoglobulin E + dinitrophenolPEP+/+ IgE DEXPEST-domain-enriched tyrosine phosphatase WTImmunoglobulin E + dexamethsonePEP+/+ IgE DNP DEXPEST-domain-enriched tyrosine phosphatase WTImmunoglobulin E + dinitrophenol + dexamethsonePEP−/− IgEPEST-domain-enriched tyrosine phosphatase mutantImmunoglobulin EPEP−/− IgE DNPPEST-domain-enriched tyrosine phosphatase mutantImmunoglobulin E + dinitrophenolPEP−/− IgE DEXPEST-domain-enriched tyrosine phosphatase mutantImmunoglobulin E + dexamethsonePEP−/− IgE DNP DEXPEST-domain-enriched tyrosine phosphatase mutantImmunoglobulin E + dinitrophenol + dexamethsone

2.2. Preparation of libraries, sequencing and data analysis {#s0020}
-----------------------------------------------------------

For the RNAseq experiment, total RNA was extracted from 3×10^6^ PEP+/+ and PEP−/− BMMCs using innuPREP RNA Mini Kit (Analytik Jena AG, Jena, Germany). A total of 1 µg RNA was used to prepare mRNA sequencing libraries for each sample using the TruSeq stranded mRNA kit v2 (Illumina), according to the vendor´s protocol. Next, 10 pM of multiplexed libraries were used to generate clusters in 2 lanes of a high-throughput flowcell. A HiSeq. 1500 was used to obtain paired-end reads of 50 bases using the sequencing by synthesis (SBS v3 kit Illumina). The cluster detection and the base calling were done with the software RTA (v1.13 Illumina) and demultiplexing with the software CASAVA (v1.8.1 Illumina). The sequencing resulted in 576 million reads with a mean quality Phred score of 35.2. The quality of the sequencing data was first assessed with FASTX toolkit (v0.0.13 \[<http://hannonlab.cshl.edu/fastx_toolkit/>\]) and no pre-processing was needed. The alignment of the sequencing reads was done with Tophat2 (v2.0.11) [@bib2] against the mouse reference genome (GRCm38 v75). The raw count per gene was calculated using HTSeq (v0.5.3) [@bib3]. The normalization of the counts, the differential expression analysis were done using the R software packages including DESeq. 2 [@bib4]. The reproducibility of the biological replicates for all the conditions examined was assessed by Principal Component Analysis ([Fig. 1](#f0005){ref-type="fig"}). The significantly deregulated genes for each paired comparison were subjected to hierarchical clustering using *hclust* and *gplot* R packages. These were done for the activation of the mast cells by antigen (DNP) alone ([Fig. 2](#f0010){ref-type="fig"}) or together with DEX treatment ([Fig. 3](#f0015){ref-type="fig"}).Fig. 1Principal Component Analysis (PCA) plot of normalized expression for the samples.Fig. 1Fig. 2Heatmap illustration of gene expression in sensitized (IgE) and activated (IgE + DNP) mast cells: Color-coded heatmap of the normalized expression level of genes representing two replicates each for PEP+/+ and PEP−/− BMMCs. The color gradient shows blue for low and red for high expression of genes.Fig. 2Fig. 3Heatmap illustration of gene expression pattern in activated (IgE + DNP) and activated mast cells treated with dexamethasone (IgE + DNP + DEX). Color-coded heatmap of the normalized expression level of genes representing two replicates for PEP+/+ and PEP−/− BMMC. The color gradient shows blue for low expression and red for high expression.Fig. 3

2.3. Validation of distinct target genes {#s0025}
----------------------------------------

KEGG pathway analysis of genes significantly deregulated upon PEP gene deletion was carried out using DAVID [@bib5]. Genes associated with antigen receptor (FcεRI signaling pathway) (IL 13, TNFα, and CSF2) and arachidonic acid metabolism pathway (COX-2, PTGDS) were some of the key genes identified to be deregulated in response to antigen and glucocorticoid respectively. A further validation of these results was carried out using qRT-PCR analyses. 1 µg of RNA was reversed transcribed to complementary DNA (cDNA) and used for real-time PCR (StepOnePlus Life Technologies, Carlsbad, California) with gene-specific primers for the following genes: IL 13 (Forward 5′-TGGCTCTTGCTTGCCTTGGT-3′, Reverse 5′-TTTTGGTATCGGGGAGGCTGG-3′), TNFα (Forward 5′-GATCGGTCCCCAAAGAAGGGATG-3′, Reverse 5′-TGATCTGAGTGTGAGGGTCTCG-3′), CSF2 (Forward 5′-TCGTCTCTAACGAGTTCTCCTT-3′, Reverse 5′-CGTAGACCCTGCTCGAATATCT-3′), COX-2 (Forward 5′-TGAGCAACTATTCCAAACCAGC-3′, Reverse 5′-GCACGTAGTCTTCGATCACTATC-3′), PTGDS (Forward 5′-GCTCCTTCTGCCCAGTTTTCCT-3′, Reverse 5′-GGAGGACCAAACCCATCCAC-3′) and in parallel with a reference gene Ribosomal protein large P0 subunit (Rplp0) (Forward 5′-GGACCCGAGAAGACCTCCTT-3′, Reverse 5′-GCACATCACTCAGAATTTCA-3′). The gene-specific primers were designed using the publicly available web-based tool 'Primer-BLAST' NCBI-NIH. The relative mRNA transcript abundance for the test genes in each sample was calculated using the 2^−(ΔΔCT)^ method [@bib6] for the role of PEP in antigen-mediated mast cell activation ([Fig. 4](#f0020){ref-type="fig"}A) and the effect of DEX on antigen-mediated mast cell activation ([Fig. 4](#f0020){ref-type="fig"}B).Fig. 4qRT-PCR validation of the expression of some genes differentially misregulated in the RNA-seq studies. **A**. Gene expression pattern of cytokine/chemokine genes identified to be differentially misregulated in response to antigen (IgE + DNP) compared to IgE treatment. The results are presented as the mean ± standard error of mean. \* *p* \< 0.05, \*\*\* *p* \< 0.001 for unpaired two-tailed *t* test (*n* = 3). **B**. Dexamethasone-induced regulation of expression of lipid mediator genes, COX-2 (cyclooxygenase-2) and PTGDS (prostaglandin D2 synthase - lipocalin-type) identified as differentially misregulated in PEP−/− BMMCs compared to the PEP+/+ BMMCs. The results are presented as the mean ± standard error of mean. \* *p* \< 0.05, \*\* *p* \< 0.01 for unpaired two tail *t* test (*n* = 5).Fig. 4
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